89BIO, INC. - Annual Financials - Income Statement (SEC)

Updated on January 2, 2026.
Related Topics: SEC Topic List.
Data Source: SEC.

See details in table below.

You can see similar for other companies.

89BIO, INC. - Annual Income Statement (In Thousands of USD, Except Per Share Amounts)
Breakdown 2024-12-31 2023-12-31 2022-12-31
Research and development 345037 122230 80796
General and administrative 39619 28974 21453
Total operating expenses 384656 151204 102249
Loss from operations -384656 -151204 -102249
Interest expense 5290 4794 1922
Interest income and other, net 23559 17676 2164
Net loss before income tax -366387 -138322 -102007
Income tax expense 692 3867 19
Net loss -367079 -142189 -102026
Unrealized gain (loss) on marketable securities 364 547 -299
Foreign currency translation adjustments 9 -7 13
Total other comprehensive income (loss) 373 540 -286
Comprehensive loss -366706 -141649 -102312
Basic Earnings Per Share -3.51 -2 -2.93
Diluted Earnings Per Share -3.51 -2 -2.93
Basic Weighted Average Shares Outstanding 104714.613 71172.87 34806.349
Diluted Weighted Average Shares Outstanding 104714.613 71172.87 34806.349